Bone Therapeutics SA, a biotechnology company, engages in the development of cell therapy products for orthopedics and bone diseases. Its products include ALLOB, an allogeneic cell therapy product, which is in Phase I/IIa studies for the treatment of delayed-union fractures and lumbar spinal fusion. The company is also developing JTA-004, an intra-articular injectable, which is in phase III development for the treatment of osteoarthritic pain in the knee. Bone Therapeutics SA has collaborations with Cerhum, 3D-Side, mSKIL, and IREC to develop personalized, tissue engineered bone implants. The company was incorporated in 2006 and is based in Gosselies, Belgium.